There were almost 1,400 new confirmed cases of coronavirus recorded across Lancashire over the weekend, as virus-related deaths rose by 28.
Saturday saw 742 people receive positive test results for Covid-19, according to data from Public Health England, in what was a comparatively low rise compared to last week there daily increases were regularly above 1,000 new cases.
There has been an overall downward trend, with infection rates in the county dropping over the last 10 days.
This trend was echoed in Sunday’s data release from PHE, with 636 new cases of the virus recorded in Lancashire in what was the lowest daily increase for a number of weeks.
Sunday was also the first day in weeks that every area of Lancashire recorded less than 100 new cases of the virus on any single day.
The fall in cases echoes where the ‘R number’ in the North West now sits, with it now estimated to be between 0.9 and 1.1 The growth of the virus per day is also between -1% and 1%.
This means that for every 100 cases of the virus, there are an extra 90 to 110 new infections, meaning the spread of the virus could very well be reducing if the R number is below 1.
Confirmed cases of coronavirus by Lancashire borough as of Sunday, November 15, with latest daily increase in brackets:
The data below includes the total number of cases and overall infection rate for each area since the pandemic began. Many of these cases will no longer be active. For the latest infection rates or the most recent week of data, click here.
- Blackburn with Darwen: 8,600 (+99), 5,745 per 100,00
- Blackpool: 4,712 (+80), 3,379.1 per 100,000
- Burnley: 3,997 (+50), 4,495.1 per 100,000
- Chorley: 3,191 (+33), 2,699.3 per 100,000
- Fylde: 2,210 (+35), 2,735.8 per 100,000
- Hyndburn: 3,233 (+54), 3,989.2 per 100,000
- Lancaster: 3,799 (+21), 2,601.4 per 100,000
- Pendle: 4,123 (+64), 4,476.1 per 100,000
- Preston: 6,385 (+53), 4,460.8 per 100,000
- Ribble Valley: 1,844 (+21), 3,028.5 per 100,000
- Rossendale: 2,833 (+26), 3,963.2 per 100,000
- South Ribble: 3,120 (+26), 2,816.2 per 100,000
- West Lancashire: 4,029 (+42) 3,488 per 100,000
- Wyre: 3,129 (+32), 2,761.1 per 100,000
Covid-related deaths across Lancashire rose by 28 over the weekend, with data from NHS England confirming the majority of these were reported on Saturday where there were 21 fatalities.
Eight of the deaths took place at East Lancashire Hospitals NHS Trust, which manages Royal Blackburn Hospital. Five people died at Lancashire Teaching Hospitals NHS Foundation Trust, which manages Royal Preston Hospital and Chorley Hospital.
There were four deaths at University Hospitals Of Morecambe Bay NHS Foundation Trust, which controls Royal Lancaster Infirmary, and three at Blackpool Teaching Hospitals NHS Foundation Trust, which runs Blackpool Victoria Hospital.
One person died at Southport and Ormskirk Hospital NHS Trust.
On Sunday, there were seven fatalities, with four of these taking place at Blackpool Teaching Hospitals NHS Foundation Trust.
Two people passed away under the care of staff at University Hospitals Of Morecambe Bay NHS Foundation Trust, with one person dying at Lancashire Teaching Hospitals.
It puts Lancashire’s total Covid-related death toll at 1,549 since the pandemic first hit the United Kingdom.
Total coronavirus deaths across Lancashire’s five NHS hospital trusts as of Sunday, November 15
- Blackpool Teaching Hospitals NHS Foundation Trust: 364 deaths
- East Lancashire Hospitals NHS Trust: 361 deaths
- Lancashire Teaching Hospitals NHS Foundation Trust: 342 deaths
- Southport and Ormskirk Hospital NHS Trust: 218 deaths
University Hospitals Of Morecambe Bay NHS Foundation Trust: 264 deaths
The tragic news comes as further vaccine hope was given by Ugur Sahin, chief executive of BioNTech, who announced promising preliminary results of its coronavirus vaccine with Pfizer, saying the companies did not see any serious side effects of the jab.
He said the “key side effects” seen so far were a mild to moderate pain in the injection site for a few days, while some of the participants had a mild to moderate fever for a similar period.
“We did not see any other serious side effects which would result in pausing or halting of the study,” he told BBC’s The Andrew Marr Show.
“We have now safety data for a proportion of the subjects for more than two months, and we are continuing to collect data for more than two years, to not only see the short and mid-term side effect profile but also the long-term side effect profile. But so far the safety profile appears to be absolutely benign.”